glp-1 medications in the workplace Navigate Employer FAQs on the Rise

It can also make stopping suddenly dangerous for some people

SC-islets also exhibited reduced expression of islet hormones, with exception of GHRL , lower levels of and cell maturation markers, relative hyporesponsiveness of insulin release to glucose- and KCl-stimulation, and lower insulin content compared to primary human islets (Fig

The first analyzed a large database of electronic health records

These drugs have been associated with numerous severe complications, including: Gastrointestinal Injuries: Gastroparesis (stomach paralysis) Severe bowel obstruction requiring hospitalization Chronic nausea, vomiting, and dehydration Gastroesophageal reflux disease (GERD) Gallbladder and Liver Problems: Acute gallbladder disease (cholecystitis) Gallstone formation Chronic gallbladder inflammation Liver failure in severe cases Kidney and Pancreatic Complications: Acute kidney injury or failure Pancreatitis requiring hospitalization Increased risk of pancreatic cancer Other Serious Conditions: Thyroid tumors or cancer Severe dehydration and malnutrition Intestinal injuries leading to death in extreme cases How GLP-1 Drugs Cause Stomach Paralysis and Other Injuries The mechanism that makes GLP-1 drugs effective for weight loss slowing gastric emptying can also cause serious harm